![Tom Burt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Burt
Direktor/Vorstandsmitglied bei
Synthace Ltd.
Profil
Thomas Henry Burt is currently a Director at Synthace Ltd., a Partner at Sofinnova Partners SAS, and a Member of the Association of Engineering Doctorates.
He previously worked as an Investment Director at Ares Life Sciences LP, an Investment Director at Novo Holdings Ltd., an Associate at Piper Sandler Ltd., and an Associate at Novo Principal Investments.
He also served as a Non-Executive Director at Redx Pharma Plc from 2020 to 2023 and as an Assistant Director at Peel Hunt LLP from 2015 to 2017.
Burt holds a graduate degree from the University of Birmingham and undergraduate and doctorate degrees from University College London.
Aktive Positionen von Tom Burt
| Unternehmen | Position | Beginn |
|---|---|---|
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01.06.2017 |
Synthace Ltd.
 Synthace Ltd. Packaged SoftwareTechnology Services Develops life sciences R&D cloud platform | Direktor/Vorstandsmitglied | 12.11.2021 |
Association of Engineering Doctorates | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Tom Burt
| Unternehmen | Position | Ende |
|---|---|---|
| REDX PHARMA LTD | Direktor/Vorstandsmitglied | 01.09.2023 |
Peel Hunt LLP
 Peel Hunt LLP Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 28.04.2017 |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal invests in public and private companies located across Europe and North America. The firm focuses on companies operating in the fields of healthcare and life science sectors. It provides financing for later stage capital requirements. | Private-Equity-Analyst | 31.01.2013 |
Novo Holdings Ltd.
 Novo Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Chief Investment Officer | - |
Ares Life Sciences LP
 Ares Life Sciences LP Investment ManagersFinance Acts as Private Equity Fund | Chief Investment Officer | - |
Ausbildung von Tom Burt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
36
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Piper Sandler Ltd.
 Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Finance |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ares Life Sciences LP
Ares Life Sciences LP Investment ManagersFinance Acts as Private Equity Fund | Finance |
Novo Principal Investments
Novo Principal Investments Investment ManagersFinance Novo Principal invests in public and private companies located across Europe and North America. The firm focuses on companies operating in the fields of healthcare and life science sectors. It provides financing for later stage capital requirements. | Finance |
Redx Pharma Plc
 Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease | Health Technology |
Peel Hunt LLP
Peel Hunt LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
Novo Holdings Ltd.
Novo Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Develops life sciences R&D cloud platform | Technology Services |
Association of Engineering Doctorates |
